Randomized placebo-controlled study of the efficacy of botulinum toxin type A (Botox) in spontaneous pain and allodynia related to traumatic nerve injury or postherpetic neuralgia
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2008
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- 21 Nov 2008 Results have been published in Annals of Neurology 64: 274-284, No. 3, Sep 2008.
- 21 Sep 2007 New trial record.